Apogee Therapeutics, Inc. APGE Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s total current liabilities?
- Apogee Therapeutics, Inc. (APGE) reported total current liabilities of $32.95M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Apogee Therapeutics, Inc.'s total current liabilities decreased by 0.0% year-over-year, from $32.96M to $32.95M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s total current liabilities?
- Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s total current liabilities has grown at a 40.9% compound annual growth rate (CAGR), from $9.98M to $27.91M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.